Cosmos Health (COSM) vs McKesson (MCK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
McKesson (MCK) has outperformed Cosmos Health (COSM) over the past year, gaining 21.4% versus a loss of 68.8%. Over five years, MCK leads with a +345.9% price change compared with -92.5% for COSM. McKesson is the larger company by market cap ($107.41 billion vs $29.6 million), about 3631.6 times the size.
On valuation, Cosmos Health trades at a lower forward P/E (4.2x vs 18.3x for McKesson). McKesson pays a dividend yielding 0.36%, while Cosmos Health does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COSM | MCK |
|---|---|---|
| Share price | $0.2939 | $921.25 |
| Market cap | $29.58M | $107.41B |
| 1-day change | -8.42% | +1.20% |
| YTD return | -35.56% | +10.98% |
| 1-year return | -68.84% | +21.36% |
| 5-year return | -92.47% | +345.87% |
| P/E ratio (TTM) | — | 24.69 |
| Forward P/E | 4.20 | 18.26 |
| EPS (TTM) | $-0.65 | $37.31 |
| Dividend yield | 0.00% | 0.36% |
| Annual dividend | $0.00 | $3.28 |
| Revenue (latest FY) | — | $403.43B |
| Revenue growth (YoY) | — | +12.36% |
| Net income (latest FY) | — | $4.76B |
| Gross margin | — | 3.61% |
| Operating margin | — | 1.54% |
| Net margin | — | 1.18% |
| 52-week high | $1.32 | $999.00 |
| 52-week low | $0.162 | $723.68 |
| Distance from 52-week high | -77.73% | -7.78% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +6.09% |
| Average volume | 4.24M | 922.54K |
| Shares outstanding | 100.63M | 116.59M |
| Employees | — | 41,600 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- McKesson is about 3631.6 times larger than Cosmos Health by market value ($107.41B vs $29.58M).
- MCK has outperformed COSM by 90.2 percentage points over the past year.
About McKesson
MCK stock →McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Health Care · Other Pharmaceuticals · 41,600 employees
COSM vs MCK FAQ
Which is bigger, Cosmos Health or McKesson?
McKesson (MCK) is larger, with a market capitalization of $107.41B compared with $29.58M for Cosmos Health (COSM).
Which stock has performed better over the past year, COSM or MCK?
MCK returned +21.36% over the past 12 months, compared with -68.84% for COSM (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Cosmos Health or McKesson?
McKesson pays a dividend yielding 0.36%, while Cosmos Health does not currently pay a regular dividend.
Are Cosmos Health and McKesson in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.